These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension. Beghetti M; Rudzinski A; Zhang M BMC Cardiovasc Disord; 2017 Jul; 17(1):177. PubMed ID: 28676038 [TBL] [Abstract][Full Text] [Related]
63. Ivabradine in pulmonary arterial hypertension: can we delay the need for parenteral prostanoid therapy? Correale M; Montrone D; Ieva R; Di Biase M; Brunetti ND Clin Res Cardiol; 2013 May; 102(5):391-3. PubMed ID: 23389056 [No Abstract] [Full Text] [Related]
64. Effect of Treprostinil on the Early Postoperative Prognosis of Patients with Severe Left Heart Valvular Disease Combined with Severe Pulmonary Hypertension. Huang ST; Xu N; Sun KP; Chen Q; Cao H Ann Thorac Cardiovasc Surg; 2021 Feb; 27(1):18-24. PubMed ID: 32493870 [TBL] [Abstract][Full Text] [Related]
65. [Clinical analysis of 79 pulmonary arterial hypertension cases from 1892 connective tissue disease patients]. Lei YX; Zhang X; Cui Y; Dong GF; Luo RQ Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(41):2934-7. PubMed ID: 20137654 [TBL] [Abstract][Full Text] [Related]
66. Tadalafil as monotherapy and in combination regimens for the treatment of pulmonary arterial hypertension. Udeoji DU; Schwarz ER Ther Adv Respir Dis; 2013 Feb; 7(1):39-49. PubMed ID: 23129569 [TBL] [Abstract][Full Text] [Related]
67. Recurrent but Preventable Pulseless Electrical Activity Arrest: Follow the Guidelines! El Hajj MC; Cai AW; Houston BA; Tedford RJ Circ Heart Fail; 2020 Mar; 13(3):e006781. PubMed ID: 32156168 [No Abstract] [Full Text] [Related]
68. Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease. Faria-Urbina M; Oliveira RKF; Agarwal M; Waxman AB Lung; 2018 Apr; 196(2):139-146. PubMed ID: 29275453 [TBL] [Abstract][Full Text] [Related]
69. Pulmonary hypertension-"state of the art" management in 2012. Saxena A Indian Heart J; 2012; 64(1):60-73. PubMed ID: 22572428 [TBL] [Abstract][Full Text] [Related]
70. [Management of borderline pulmonary arterial hypertension associated with connective tissue diseases]. Yoshifuji H; Kinoshita H Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):454-61. PubMed ID: 25748129 [TBL] [Abstract][Full Text] [Related]
71. Predictive factors associated with increased progression to dialysis in early chronic kidney disease (stage 1-3) patients. Nohara N; Io H; Matsumoto M; Furukawa M; Okumura K; Nakata J; Shimizu Y; Horikoshi S; Tomino Y Clin Exp Nephrol; 2016 Oct; 20(5):740-747. PubMed ID: 26707759 [TBL] [Abstract][Full Text] [Related]
73. [Risk factors for pulmonary hypertension at the predialysis stage of chronic kidney disease]. Rudenko TE; Vasilyeva MP; Solomakhina NI; Kutyrina IM Ter Arkh; 2016; 88(6):33-39. PubMed ID: 27296259 [TBL] [Abstract][Full Text] [Related]
74. Long-term outcomes of surgery for chronic thromboembolic pulmonary hypertension compared with medical therapy at a single Korean center. Kim SH; Lee JW; Ahn JM; Kim DH; Song JM; Lee SD; Lee JS Korean J Intern Med; 2017 Sep; 32(5):855-864. PubMed ID: 27733022 [TBL] [Abstract][Full Text] [Related]
75. Left heart abnormalities in connective tissue disease patients with pre-capillary pulmonary hypertension as well as borderline mean pulmonary arterial pressure. Tsuchida K; Yamada H; Yamasaki Y; Suzuki K; Kongoji K; Akashi Y; Ozaki S Mod Rheumatol; 2015 Sep; 25(5):744-7. PubMed ID: 25736353 [TBL] [Abstract][Full Text] [Related]
76. Does Portopulmonary Hypertension Impede Liver Transplantation in Cirrhotic Patients? A French Multicentric Retrospective Study. Reymond M; Barbier L; Salame E; Besh C; Dumortier J; Pageaux GP; Bureau C; Dharancy S; Vanlemmens C; Abergel A; Woehl Jaegle ML; Magro P; Patat F; Laurent E; Perarnau JM Transplantation; 2018 Apr; 102(4):616-622. PubMed ID: 29077657 [TBL] [Abstract][Full Text] [Related]
77. Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension. Kularatne M; Boucly A; Savale L; Solinas S; Cheron C; Roche A; Jevnikar M; Jaïs X; Montani D; Humbert M; Sitbon O Expert Opin Pharmacother; 2023; 24(18):2101-2115. PubMed ID: 37869785 [TBL] [Abstract][Full Text] [Related]